Heart failure with reduced ejection fraction due to dilated cardiomyopathy in a patient with hypocalcemic cardiomyopathy, secondary to primary hypoparathyroidism.
The delayed titration of guideline-directed medical therapy is complex and often results in poor prognosis for heart failure patients. Are you using GDMT in the most effective way?
Managing patients with acute or chronic HFpEF and concurrent hypertension is difficult. Make sure you're confident prescribing the optimal drug combination.
STEP-HFpEF trial findings indicate that weekly semaglutide improves heart failure symptoms, physical limitations, and body weight in people with obesity-related heart failure and type 2 diabetes.
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.
Heart failure with reduced ejection fraction due to dilated cardiomyopathy in a patient with hypocalcemic cardiomyopathy, secondary to primary hypoparathyroidism.
Assessing heart failure progression in patients with Duchenne muscular dystrophy is challenging due to the multisystem nature of the disease. This is the first use of an implantable pulmonary artery pressure monitor.
A 63-year-old woman presented with multiple, short-succession hospital admissions for heart failure and sustained hypertension despite intensive therapy. A diagnosis of a secondary hyperaldosteronism was made, resulting from renal hypoperfusion due to narrowing of the thoracic aorta by a huge calcified plaque, mimicking an aortic coarctation.
Heart failure poses a global health challenge affecting millions of individuals, and access to guideline-directed medical therapy is often limited. This limitation is frequently attributed to factors such as drug availability, slow adoption …
Heart failure continues to be a significant global health concern, causing substantial morbidity and mortality. The limited ability of the adult heart to regenerate has posed challenges in finding effective treatments for cardiac pathologies.
Cardiac resynchronization therapy (CRT) is a proven therapy for patients with heart failure (HF) with reduced left ventricular ejection fraction (LVEF) and left bundle branch block (LBBB) who remain symptomatic despite being on optimal …
Heart failure (HF) is a major public health problem worldwide, affecting more than 64 million people [ 1 ]. The prevalence of HF is increasing due to aging populations, improved survival from cardiovascular diseases, and the growing burden of risk …
An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.
This article is published with digital features, including an infographic, to facilitate understanding of the article. To view digital features for this article, go to https://doi.org/10.6084/m9.figshare.25352206 .
Cardiac disease is the leading cause of death in both urban and rural residents in China. High long-term mortality is mostly caused by HF and other MACE following AMI [ 1 ]. PCI and guideline-directed medical therapy can reduce the in-hospital …
Heart failure continues to be a significant global health concern, causing substantial morbidity and mortality. The limited ability of the adult heart to regenerate has posed challenges in finding effective treatments for cardiac pathologies.
In the turn of the century, transcatheter aortic valve replacement (TAVR) has gradually overtaken surgical aortic valve replacement (SAVR) as the leading intervention for patients with aortic stenosis. 1 While the rates of procedural success is …
